ARQTArcutis Biotherapeutics, Inc.ToppingEarnings in 8 days
TodayToppingjumpy stock
31.81+1.96% todayClose of Oct 26, 2026 · end-of-day snapshot
Not sure what's inside? Read a full TSLA analysis, currently free
Technical readingsFree
Uptrend, orderlySee the full setup read: unlock ARQT
Trend state Topping, stage 3 of 4, 2 of 4 damage flags raised (as of Oct 26, 2026)
Automated read
Price is trading above its key moving averages and momentum readings are contained: the mid-term picture reads as an orderly uptrend. RSI is currently 66.
Readings, end-of-day Oct 26, 2026
RSI (14)Upper-neutral66.39, favorable reading
MACD / signalAbove signal line1.72 / 1.20, favorable reading
SMA 50Price above26.20, favorable reading
SMA 200Price above25.15, favorable reading
EMA 20Price above28.81, favorable reading
ADX (14)Trending32.19
Show all 12 readings
+DI / −DI+DI leading33.95 / 12.44, favorable reading
ATR (14)5.0% of price — elevated daily swings1.60, flagged reading
Stochastic %KOverbought zone84.99, flagged reading
Bollinger bands (20)Inside bands21.67 – 33.97
ROC (10)Positive over 10 sessions21.32, favorable reading
Trend / momentum impulseTrend and momentum disagreeMixed
Full analysis
What unlocking ARQT reveals
Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock
Generated on unlock: written when ARQT's analysis runs, rather than checked against its stored data now.
Every section above, argued on ARQT's own numbers, on one page.
See what ARQT costsNot sure what's inside? Read a full TSLA analysis, currently freeUnlock the full ARQT analysis
AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.
- Unlocked in about 60 seconds
- No account needed
- Secure checkout via Stripe
Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.
Free weekly sample report
Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.
Need the raw data?Get ARQT + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset Earnings
When does Arcutis Biotherapeutics, Inc. report earnings?
Arcutis Biotherapeutics, Inc. (ARQT) is scheduled to report earnings on Nov 4, 2026.
The date is confirmed rather than estimated, though companies do occasionally reschedule.
Data as of Oct 27, 2026
See who else reports soon$9.90one-time Unlock ARQT